at a 20% discount to Novo Nordisk’s brand. The new spending comes after announcements of 40 billion DKK in production investments in the last two years, including spending on a new facility in ...

For the full year 2024, Novo Nordisk said it plans to allocate $6.8 billion to production, up 74% from a year earlier. The North Carolina facility represents one of the biggest manufacturing ...

The world's largest insulin production plant is to expand as Novo Nordisk announced work has begun to add a further 500 square metres to its facility in Kalundborg, Denmark. Novo is to invest a ...

In a supply update on the drug dated Friday, Novo Nordisk said that “demand continues to outpace our increasing production of Wegovy. As a result, we anticipate ongoing supply disruption ...

Novo Nordisk has been slowly increasing production capacity of its highly coveted weight loss drugs. As a result, thousands of people have began treatment per week. Wegovy has been FDA-approved ...

Novo Nordisk A/S (NVO) investors who had anticipated that the stock could continue outperforming the market were likely disappointed. Accordingly, NVO has underperformed the S&P 500 (SPX ...

(Reuters) -Danish drugmaker Novo Nordisk said on Tuesday it has mitigation plans in place to minimize or prevent any disruption to its production due to sea port strikes in the United States.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity ...

Catalent, a leading contract drug manufacturer, issued an open letter on Monday to reassure customers that a proposed $16.5 billion deal — in which it would be acquired by Novo Nordisk’s ...

Oct 21 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said on Monday an oral version of its drug semaglutide, helped significantly reduce the risk of cardiovascular events in patients in a ...